The National Pharmaceutical Pricing Authority, the regulatory authority for medical devices and drugs, has allowed manufacturers and importers of knee implants to revise their costs for a period of one year, .i.e. till September 2024
The price monitoring and resource unit (PMRU) will function at the state level under the direct supervision of the state drug controller for increasing outreach of the NPPA
